The contractor shall provide niaid with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products…
Active Awarded Last action
- Contract number
- 75N93022D00002
- Awardee
-
Mriglobal UEI HKQHNFKNKL15
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $2,167,699 obligated
Award facts
- Opportunity
-
- Preclinical and translational vaccine development for HIV and other candidate agents Pre-Solicitation · 75N93019R00023 · Posted Mar 26, 2020
- Combined order value
-
- $2,167,699 Current, with exercised options
- $2,873,108 Potential, with all options
- Last date to order 70% complete
- IDV ceiling 1% used
- $364,553,934.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a multiple-award indefinite-delivery contract to Mriglobal (doing business as Midwest Research Institute) on December 1, 2021, for preclinical and translational vaccine development support for HIV and other candidate agents, with a contract ceiling of $364,553,934.
Work is performed in Kansas City, Missouri, with subordinate operational sites in North Kansas City, Potomac, Maryland, Frederick, Maryland, Edison, New Jersey, and other locations. The contract supports a broad range of capabilities required for preclinical and translational development of promising vaccines and related products, including product storage and shipping, safety and immunogenicity studies, feasibility assessments, analytical development, process development, current good manufacturing practice (CGMP) manufacturing, stability testing, fill-finish operations, and scientific and quality support.
The period of performance runs through November 30, 2028. The underlying solicitation, posted March 26, 2020, anticipated awarding approximately 15 to 20 task orders annually with combined values ranging from $98 million to $318 million over the seven-year contract period. Task Area G for scientific, quality, and regulatory support services was set aside for small business concerns only; the remainder was full and open. The applicable NAICS code is 541715 (research and development in biotechnology).
A delivery order issued under this IDIQ on December 1, 2021, valued at $2,873,108 and performed in Kansas City, Missouri, covers research and development product storage and shipping in support of preclinical and translational vaccine development. The order is structured on a cost-plus-fixed-fee basis with completion scheduled for November 30, 2028, and includes subcontracted ultra-cold transfer services through Brazos Relocation Services Inc.
Description
The contractor shall provide niaid with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products for HIV and other candidate agents. The contractor
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Research and development product storage and shipping | National Institute of Allergy and Infectious Diseases (NIH) | $2,167,699 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93022D00002?
75N93022D00002 was awarded to Mriglobal by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2021.
How much is contract 75N93022D00002 worth?
Orders under 75N93022D00002 have obligated $2,167,699. Their combined potential value, with all options, is $2,873,108. 75N93022D00002's own ceiling is $364,553,934.
How many orders have been placed under contract 75N93022D00002?
1 order has been placed under 75N93022D00002, the latest on December 1, 2021.
Who can order from contract 75N93022D00002?
75N93022D00002 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93022D00002 part of a contract vehicle?
Yes. 75N93022D00002 is part of Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
Was contract 75N93022D00002 competed?
The extent of competition for 75N93022D00002 was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV